HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Is apolipoprotein(a) a susceptibility gene for type I diabetes mellitus and related to long-term survival?

AbstractAIMS/HYPOTHESIS:
High lipoprotein(a) [Lp(a)] plasma concentrations are a genetically determined risk factor for atherosclerotic complications. In healthy subjects Lp(a) concentrations are mostly controlled by the apolipoprotein(a) [apo(a)] gene locus which determines a size polymorphism with more than 30 alleles. Subjects with low molecular weight apo(a) phenotypes on average have higher Lp(a) concentrations than those with high molecular weight apo(a) phenotypes. There are many opinions about whether and why Lp(a) is raised in patients with Type I diabetes (insulin-dependent) mellitus.
METHODS:
We investigated Lp(a) plasma concentrations and apo(a) phenotypes in 327 patients with Type I diabetes mellitus (disease duration 1-61 years) and in 200 control subjects matched for age and sex.
RESULTS:
Patients with a disease duration of up to 15 years had significantly higher Lp(a) concentrations (24.3 +/- 34.0 mg/dl vs 16.7 +/- 22.6 mg/dl, p = 0.014) compared with control subjects. This increase can be explained by a considerably higher frequency of low molecular weight apo(a) phenotypes (38.9% vs 23.5%, p < 0.005). The frequency of low molecular weight apo(a) phenotypes decreased continuously with disease duration from 41.7% in those with disease duration of up to 5 years to 18.2% in those with the disease lasting more than 35 years.
CONCLUSIONS/INTERPRETATION:
Our data show that an increase of Lp(a) in Type I diabetic patients can only be observed in groups with short diabetes duration and that this elevation is genetically determined. Therefore, the apo(a) gene, located at 6q26-27, might be a susceptibility gene for Type I diabetes mellitus which is supported by recently published studies reporting evidence for linkage of this region (6q27) with Type I diabetes mellitus. Furthermore, the decreasing frequency of low molecular weight apo(a) phenotypes with disease duration suggests a survivor effect.
AuthorsF Kronenberg, M Auinger, E Trenkwalder, K Irsigler, G Utermann, H Dieplinger
JournalDiabetologia (Diabetologia) Vol. 42 Issue 8 Pg. 1021-7 (Aug 1999) ISSN: 0012-186X [Print] Germany
PMID10491765 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Apolipoproteins A
  • Glycated Hemoglobin A
  • Lipoprotein(a)
Topics
  • Adult
  • Albuminuria
  • Apolipoproteins A (genetics)
  • Diabetes Mellitus, Type 1 (blood, genetics, mortality)
  • Female
  • Genetic Predisposition to Disease
  • Glycated Hemoglobin (analysis)
  • Humans
  • Lipoprotein(a) (blood, genetics)
  • Male
  • Phenotype
  • Polymorphism, Genetic
  • Proteinuria
  • Reference Values
  • Survivors
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: